6-80169031-G-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_183050.4(BCKDHB):c.633+1G>T variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_183050.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BCKDHB | NM_183050.4 | c.633+1G>T | splice_donor_variant, intron_variant | Intron 5 of 9 | ENST00000320393.9 | NP_898871.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BCKDHB | ENST00000320393.9 | c.633+1G>T | splice_donor_variant, intron_variant | Intron 5 of 9 | 1 | NM_183050.4 | ENSP00000318351.5 | |||
BCKDHB | ENST00000356489.9 | c.633+1G>T | splice_donor_variant, intron_variant | Intron 5 of 10 | 1 | ENSP00000348880.5 | ||||
BCKDHB | ENST00000369760.8 | c.633+1G>T | splice_donor_variant, intron_variant | Intron 5 of 5 | 3 | ENSP00000358775.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Maple syrup urine disease Pathogenic:4
Variant summary: BCKDHB c.633+1G>T is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes the canonical 5' splicing donor site. At least one publication reports experimental evidence that this variant affects mRNA splicing (Hayashida_1994). The variant was absent in 251150 control chromosomes. c.633+1G>T has been reported in the literature in homozygosity in at-least one individual affected with Maple Syrup Urine Disease (Hayashida_1994). These data indicate that the variant is associated with disease. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as likely pathogenic citing overlapping evidence utilized in the context of this evaluation. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
This sequence change affects a donor splice site in intron 5 of the BCKDHB gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or altered protein product. This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with maple syrup urine disease (PMID: 8312380, 27507644). ClinVar contains an entry for this variant (Variation ID: 553536). Studies have shown that disruption of this splice site results in skipping of exon 5 and/or exons 5 and 6, and produces a non-functional protein and/or introduces a premature termination codon (PMID: 8312380). For these reasons, this variant has been classified as Pathogenic. -
- -
Maple syrup urine disease type 1B Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at